Abstract LB017: PDX Finder: An open and global catalogue of patient-derived xenograft models

Zinaida Perova, Csaba Halmagyi, Abayomi Mosaku, N. Conte, J. Mason, Alex Follette, Ross Thorne, Mauricio Martinez, S. Neuhauser, D. Begley, D. Krupke, H. Parkinson, T. Meehan, C. Bult
{"title":"Abstract LB017: PDX Finder: An open and global catalogue of patient-derived xenograft models","authors":"Zinaida Perova, Csaba Halmagyi, Abayomi Mosaku, N. Conte, J. Mason, Alex Follette, Ross Thorne, Mauricio Martinez, S. Neuhauser, D. Begley, D. Krupke, H. Parkinson, T. Meehan, C. Bult","doi":"10.1158/1538-7445.AM2021-LB017","DOIUrl":null,"url":null,"abstract":"Patient-derived tumor xenograft (PDX) models are a critical oncology platform for cancer research, drug development and personalized medicine. Because of the heterogeneous nature of PDXs repositories, finding models of interest is a challenge. The Jackson Laboratory and EMBL-EBI are developing PDX Finder, the world9s largest open PDX database containing millions of phenomic information from over 4300 models (www.pdxfinder.org, PMID: 30535239). In support of this initiative, we developed the PDX Minimal Information standard (PDX-MI) which defines metadata necessary to describe models (PMID: 29092942). Within PDX Finder, critical attributes like diagnosis, drug names or genes are harmonized into a cohesive ontological data model based on PDX-MI. An intuitive search and faceted search interface allow users to select models based on clinical/PDX attributes, tumor markers, dataset availability and/or drug dosing results. We provide PDX, patient, drug and molecular data detail pages where all available information can be browsed and downloaded. To further facilitate user9s model selection, we are linking key external resources like publication platforms and cancer-specific annotation tools enabling exploration and prioritization of PDX variation data (COSMIC, CIViC, OncoMx, OpenCRAVAT). Links to originating resource protocols and contact information are provided, facilitating data understanding and further collaboration. Alongside database development activities, PDX Finder has undertaken activities to tackle areas of standards and tool development, data integration and outreach. PDX Finder provides key expertise and software components to support several worldwide consortia including PDXNet, PDMR and EurOPDX. We are driving the development of, and promoting the use of descriptive standards to facilitate data interoperability and promote global sharing of models. Our standard has become established in the community for data exchange, adopted by PDX providers, consortia, and informatics tools integrating PDX data. It has been re-used by different initiatives in the context of data collection and data modeling allowing adherence to the FAIR data principles - Findability, Accessibility, Interoperability and Reusability. PDX Finder is increasing awareness of PDX models, facilitating data integration, and enabling international collaboration, maximizing the investment in, and translational capabilities of these important models of human cancer. PDX Finder is freely available under an Apache 2 license (github.com/pdxfinder). Work supported by NCI U24 CA204781 01 (ended 31Aug2020), U24 CA253539, and R01 CA089713. Citation Format: Zinaida Perova, Csaba Halmagyi, Abayomi Mosaku, Nathalie Conte, Jeremy Mason, Alex Follette, Ross Thorne, Mauricio Martinez, Steven Neuhauser, Dale Begley, Debra Krupke, Helen Parkinson, Terrence Meehan, Carol Bult. PDX Finder: An open and global catalogue of patient-derived xenograft models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr LB017.","PeriodicalId":73617,"journal":{"name":"Journal of bioinformatics and systems biology : Open access","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of bioinformatics and systems biology : Open access","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.AM2021-LB017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Patient-derived tumor xenograft (PDX) models are a critical oncology platform for cancer research, drug development and personalized medicine. Because of the heterogeneous nature of PDXs repositories, finding models of interest is a challenge. The Jackson Laboratory and EMBL-EBI are developing PDX Finder, the world9s largest open PDX database containing millions of phenomic information from over 4300 models (www.pdxfinder.org, PMID: 30535239). In support of this initiative, we developed the PDX Minimal Information standard (PDX-MI) which defines metadata necessary to describe models (PMID: 29092942). Within PDX Finder, critical attributes like diagnosis, drug names or genes are harmonized into a cohesive ontological data model based on PDX-MI. An intuitive search and faceted search interface allow users to select models based on clinical/PDX attributes, tumor markers, dataset availability and/or drug dosing results. We provide PDX, patient, drug and molecular data detail pages where all available information can be browsed and downloaded. To further facilitate user9s model selection, we are linking key external resources like publication platforms and cancer-specific annotation tools enabling exploration and prioritization of PDX variation data (COSMIC, CIViC, OncoMx, OpenCRAVAT). Links to originating resource protocols and contact information are provided, facilitating data understanding and further collaboration. Alongside database development activities, PDX Finder has undertaken activities to tackle areas of standards and tool development, data integration and outreach. PDX Finder provides key expertise and software components to support several worldwide consortia including PDXNet, PDMR and EurOPDX. We are driving the development of, and promoting the use of descriptive standards to facilitate data interoperability and promote global sharing of models. Our standard has become established in the community for data exchange, adopted by PDX providers, consortia, and informatics tools integrating PDX data. It has been re-used by different initiatives in the context of data collection and data modeling allowing adherence to the FAIR data principles - Findability, Accessibility, Interoperability and Reusability. PDX Finder is increasing awareness of PDX models, facilitating data integration, and enabling international collaboration, maximizing the investment in, and translational capabilities of these important models of human cancer. PDX Finder is freely available under an Apache 2 license (github.com/pdxfinder). Work supported by NCI U24 CA204781 01 (ended 31Aug2020), U24 CA253539, and R01 CA089713. Citation Format: Zinaida Perova, Csaba Halmagyi, Abayomi Mosaku, Nathalie Conte, Jeremy Mason, Alex Follette, Ross Thorne, Mauricio Martinez, Steven Neuhauser, Dale Begley, Debra Krupke, Helen Parkinson, Terrence Meehan, Carol Bult. PDX Finder: An open and global catalogue of patient-derived xenograft models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr LB017.
LB017: PDX Finder:一个开放和全球的患者来源的异种移植模型目录
患者源性肿瘤异种移植(PDX)模型是癌症研究、药物开发和个性化医疗的重要肿瘤学平台。由于pdx存储库的异构特性,找到感兴趣的模型是一项挑战。Jackson实验室和EMBL-EBI正在开发PDX Finder,这是世界上最大的开放PDX数据库,包含来自4300多个模型的数百万个现象信息(www.pdxfinder.org, PMID: 30535239)。为了支持这个计划,我们开发了PDX最小信息标准(PDX- mi),它定义了描述模型所需的元数据(PMID: 29092942)。在PDX Finder中,诊断、药物名称或基因等关键属性被协调到基于PDX- mi的内聚本体数据模型中。直观的搜索和分面搜索界面允许用户根据临床/PDX属性、肿瘤标志物、数据集可用性和/或药物剂量结果选择模型。我们提供PDX,患者,药物和分子数据详细页面,所有可用的信息都可以浏览和下载。为了进一步方便用户的模型选择,我们正在链接关键的外部资源,如出版平台和癌症特定的注释工具,以便对PDX变异数据(COSMIC, CIViC, OncoMx, OpenCRAVAT)进行探索和优先排序。提供了原始资源协议和联系信息的链接,以促进数据理解和进一步合作。除了数据库开发活动,PDX Finder还承担了处理标准和工具开发、数据集成和扩展等领域的活动。PDX Finder提供关键的专业知识和软件组件,以支持几个全球联盟,包括PDXNet, PDMR和EurOPDX。我们正在推动描述性标准的开发和推广使用,以促进数据互操作性和促进模型的全球共享。我们的标准已经在数据交换社区中建立起来,被PDX提供者、联盟和集成PDX数据的信息学工具所采用。它在数据收集和数据建模的背景下被不同的计划重用,从而遵守FAIR数据原则——可查找性、可访问性、互操作性和可重用性。PDX Finder正在提高人们对PDX模型的认识,促进数据集成,实现国际合作,最大限度地提高对这些重要人类癌症模型的投资和转化能力。PDX Finder在Apache 2许可下免费提供(github.com/pdxfinder)。NCI U24 CA204781 01(截止2020年8月31日)、U24 CA253539、R01 CA089713支持。引文格式:Zinaida Perova, Csaba Halmagyi, Abayomi Mosaku, Nathalie Conte, Jeremy Mason, Alex Follette, Ross Thorne, Mauricio Martinez, Steven Neuhauser, Dale Begley, Debra Krupke, Helen Parkinson, Terrence Meehan, Carol Bult。PDX Finder:一个开放和全球的病人来源的异种移植模型目录[摘要]。见:美国癌症研究协会2021年年会论文集;2021年4月10日至15日和5月17日至21日。费城(PA): AACR;癌症杂志,2021;81(13 -增刊):摘要nr LB017。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信